30 matches.
- Firm AnnouncementsLife Sciences Regulatory Attorney Alison Fethke Joins Epstein Becker Green, Strengthening Firm's FDA and Compliance Capabilities3 minute read
- Media CoverageMedia Covers Alison Fethke’s Move to Epstein Becker Green4 minute read
- EventsPatient Assistance and Access Programs (PAP) 2026 Conference: Legal Address—Stay on the Pulse of Regulatory Changes
- Events26th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress: Patient-Oriented Commercial Models - Legal and Market Access Considerations
- EventsMedicaid Drug Rebate Program Summit: Direct to Consumer Commercialization Models Market Access Considerations
- Events25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress: Exploring Risks and Enforcement Trends for Buy-and-Bill Drugs
- PublicationsFeds' Biotech Enforcement Efforts Are Too Heavy-Handed, Law360
- Events24th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress: Alternative Funding Vendors - the Future and Options for Responding to New Challenges to Patient Support Programs
- PublicationsOIG Finds Physician-Owned Medical Device Innovator Not a Suspect "POD," Westlaw Today
- EventsVirtual 22nd Annual Pharmaceutical and Medical Device Ethics and Compliance Congress: How to Establish Risk Tolerance in an Emerging Organization
- EventsPharmaceutical Compliance Congress: High-Risk Areas Related to Patient Assistance and Support Programs
- EventsDrug Pricing 2021: An Overview and the Evolving Legal and Policy Landscape
- PublicationsCompliance Considerations for Pharma Co. Testing Programs, Law360
- EventsCharitable Patient Assistance Programs: Ensuring Compliance
- EventsA&M Healthcare Industry Group: Part II, Telehealth—Addressing Necessary Regulatory and Compliance Risk
- EventsPAP 2020, 21st Annual Patient Assistance & Access Programs: Emerging Best Practices and Industry Trends in Free Drug ProgramsAugust 3–7, 2020
- EventsIPMI Healthcare General Counsel Forum: Optimizing Your Compliance, Privacy & Security, and Quality Programs
- Events20th Annual Pharmaceutical and Medical Device Compliance Congress: Medical Affairs Proactive Communications, Engagement by Manufacturers
- Events19th Annual Pharmaceutical and Medical Device Compliance Congress: Mini Summit 19: "All in Compliance"—Aligning with Your Business PartnersNovember 7–9, 2018
- PublicationsDistributors Expose Health, Life Science Companies to FCPA Risks, Law360
- EventsSeventh Annual Patient Advocacy Engagement Conference: Roundtable Discussion—Anti-Kickback Constraints on Compensating Patients
- Events3rd Annual Life Science Compliance Training Conference: Current Areas of Concern for Life Science Corporations—Foreign Corrupt Practices ActJune 6–7, 2018
- PublicationsEmerging Enforcement Trends for Patient Support Programs, Law360
- PublicationsRisky Business for Pharma, Pharmaceutical Market Europe
- EventsPharmaceutical and Medical Device Compliance Congress: Global Compliance in the Transactional Context—Due Diligence, Integration, and Post-Transaction StepsNovember 6–8, 2017
- PublicationsHow Conduct Abroad Impacts Health Care Business in US, Law360
- PublicationsValue-Based Challenges and Opportunities for Pharma Cos., Law360
- PublicationsFeatured: Helping Piece Together the Life Sciences Puzzle, Chicago Daily Law Bulletin
- EventsPharmaceutical Regulatory and Compliance Congress: Compliance Considerations in Patient Support ProgramsNovember 3–5, 2014
- PublicationsUnknowing Company Executives Held Responsible for FDCA Violations, Inside Counsel